ATRA   $5.13  8.46% Market Open

Atara Biotherapeutics, Inc.
Total Cash 35.29M
totalCashPerShare 7.18
EBITDA -162.12M
Total Debt 52.70M
quickRatio 0.254
currentRatio 0.421
Total Revenue 62.39M
debtToEquity
Revenue/Share 12.263
ROA -0.57482
ROE
grossProfits
freeCashflow -2.97M
operatingCashflow -142.01M
earningsGrowth
revenueGrowth 28.927
grossMargins -2.01896
ebitdaMargins -2.5987
operatingMargins -0.62413
profitMargins -2.90201
enterpriseValue 67.94M
forwardPE -1.1721778
floatShares 4.07M
sharesOutstanding 5.67M
sharesShort 639.15K
sharesShortPriorMonth 462.96K
dateShortInterest
sharesPercentSharesOut 0.11%
heldPercentInsiders 0.22%
heldPercentInstitutions 0.51%
Short Ratio help_outline 7.19%
shortPercentOfFloat 0.11%
impliedSharesOutstanding
bookValue -22.608
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -181.05M
trailingEps -39.00%
forwardEps -8.77%
enterpriseToEbitda -0.42
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.93 3Q 2024
institutionsCount 68
lastUpdated Nov. 6, 2024, 5:25 p.m.